Akari Therapeutics, Plc
AKTX
$1.10
-$0.095-7.98%
| Weiss Ratings | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.98 | |||
| Price History | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -16.12% | |||
| 30-Day Total Return | 12.89% | |||
| 60-Day Total Return | -22.34% | |||
| 90-Day Total Return | -11.69% | |||
| Year to Date Total Return | -9.50% | |||
| 1-Year Total Return | -23.96% | |||
| 2-Year Total Return | -72.57% | |||
| 3-Year Total Return | -95.38% | |||
| 5-Year Total Return | -96.09% | |||
| 52-Week High % Change | -72.95% | |||
| 52-Week Low % Change | 40.00% | |||
| Price | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.40 | |||
| 52-Week Low Price | $0.85 | |||
| 52-Week Low Price (Date) | Mar 03, 2025 | |||
| 52-Week High Price (Date) | Jul 26, 2024 | |||
| Valuation | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 29.46M | |||
| Enterprise Value | 28.22M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3,734.80 | |||
| Earnings Per Share Growth | -11.16% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $1.10 | |||
| Enterprise Value/EBITDA (TTM) | -2.11 | |||
| Enterprise Value/EBIT | -2.11 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 6.00K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 929 274 7510 | |||
| Address | 22 Boston Wharf Road Boston, MA 02210 | |||
| Website | www.akaritx.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -0.84% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | 58.17% | |||
| Balance Sheet | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.25M | |||
| Cash Per Share (Q) | $374.33 | |||
| Total Current Assets (Q) | 2.73M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -6.69M | |||
| Current Ratio (Q) | 0.290 | |||
| Book Value Per Share (Q) | -$1,102.40 | |||
| Total Assets (Q) | 2.73M | |||
| Total Current Liabilities (Q) | 9.43M | |||
| Total Debt (Q) | 1.00M | |||
| Total Liabilities (Q) | 9.43M | |||
| Total Common Equity (Q) | -6.69M | |||
| Cash Flow | AKTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
